ELISA Kit for Carcinoembryonic Antigen (CEA)

CD66E; CD66; CEACAM5; Carcinoembryonic Antigen-related Cell Adhesion Molecule 5; Carcinoembryonic Antigen

  • ELISA Kit for Carcinoembryonic Antigen (CEA) Packages (Simulation)
  • ELISA Kit for Carcinoembryonic Antigen (CEA) Packages (Simulation)
  • ELISA Kit for Carcinoembryonic Antigen (CEA) Results demonstration
  • SEA150Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the ELISA Kit for Carcinoembryonic Antigen (CEA)

This assay has high sensitivity and excellent specificity for detection of Carcinoembryonic Antigen (CEA).
No significant cross-reactivity or interference between Carcinoembryonic Antigen (CEA) and analogues was observed.

Recovery of the ELISA Kit for Carcinoembryonic Antigen (CEA)

Matrices listed below were spiked with certain level of recombinant Carcinoembryonic Antigen (CEA) and the recovery rates were calculated by comparing the measured value to the expected amount of Carcinoembryonic Antigen (CEA) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 87-102 99
EDTA plasma(n=5) 94-105 101
heparin plasma(n=5) 80-102 84

Precision of the ELISA Kit for Carcinoembryonic Antigen (CEA)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Carcinoembryonic Antigen (CEA) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Carcinoembryonic Antigen (CEA) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the ELISA Kit for Carcinoembryonic Antigen (CEA)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Carcinoembryonic Antigen (CEA) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 94-101% 92-101% 86-94% 95-105%
EDTA plasma(n=5) 78-101% 84-102% 86-94% 78-99%
heparin plasma(n=5) 98-105% 84-102% 95-103% 96-104%

Stability of the ELISA Kit for Carcinoembryonic Antigen (CEA)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the ELISA Kit for Carcinoembryonic Antigen (CEA)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

Test principle of the ELISA Kit for Carcinoembryonic Antigen (CEA)

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Carcinoembryonic Antigen (CEA). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Carcinoembryonic Antigen (CEA). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Carcinoembryonic Antigen (CEA), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Carcinoembryonic Antigen (CEA) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
APA150Hu61 Active Carcinoembryonic Antigen (CEA) Cell culture; Activity Assays.
EPA150Hu61 Eukaryotic Carcinoembryonic Antigen (CEA) Positive Control; Immunogen; SDS-PAGE; WB.
RPA150Hu01 Recombinant Carcinoembryonic Antigen (CEA) Positive Control; Immunogen; SDS-PAGE; WB.
RPA150Hu04 Recombinant Carcinoembryonic Antigen (CEA) Positive Control; Immunogen; SDS-PAGE; WB.
RPA150Hu03 Recombinant Carcinoembryonic Antigen (CEA) Positive Control; Immunogen; SDS-PAGE; WB.
RPA150Hu02 Recombinant Carcinoembryonic Antigen (CEA) Positive Control; Immunogen; SDS-PAGE; WB.
APA150Hu02 Active Carcinoembryonic Antigen (CEA) Cell culture; Activity Assays.
APA150Hu04 Active Carcinoembryonic Antigen (CEA) Cell culture; Activity Assays.
RPA150Hu05 Recombinant Carcinoembryonic Antigen (CEA) Positive Control; Immunogen; SDS-PAGE; WB.
PAA150Hu04 Polyclonal Antibody to Carcinoembryonic Antigen (CEA) WB
PAA150Hu03 Polyclonal Antibody to Carcinoembryonic Antigen (CEA) WB; IHC; ICC; IP.
PAA150Hu01 Polyclonal Antibody to Carcinoembryonic Antigen (CEA) WB; IHC; ICC; IP.
PAA150Hu02 Polyclonal Antibody to Carcinoembryonic Antigen (CEA) WB; IHC; ICC; IP.
LAA150Hu71 Biotin-Linked Polyclonal Antibody to Carcinoembryonic Antigen (CEA) WB; IHC; ICC.
RAA150Hu21 Recombinant Antibody to Carcinoembryonic Antigen (CEA) WB; IF; ICC; IHC; IP; FCM.
MAA150Hu22 Monoclonal Antibody to Carcinoembryonic Antigen (CEA) WB; IHC; ICC; IP.
SEA150Hu ELISA Kit for Carcinoembryonic Antigen (CEA) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA150Hu Multiplex Assay Kit for Carcinoembryonic Antigen (CEA) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA150Hu01 ELISA Kit DIY Materials for Carcinoembryonic Antigen (CEA) Main materials for "Do It (ELISA Kit) Yourself".
GUESTBOOK